Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Generalized Anxiety Disorder
Recent news which mentions Generalized Anxiety Disorder
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
March 22, 2024
Tickers
CCC
IXHL
Tags
Feldman Legal Advisors
IXHL
Psychedelic
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
MNMD
Legal
CMPS
From
Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
Tickers
IXHL
NEWS
Tags
Psychedelics
Generalized Anxiety Disorder
Biotech
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
MNMD
Psychedelics
Generalized Anxiety Disorder
From
Benzinga
Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
December 14, 2023
Tickers
MNMD
Tags
Psychedelics
Generalized Anxiety Disorder
Psychedelic/Assisted Therapies
From
Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
September 12, 2023
Tickers
MNMD
Tags
News
Generalized Anxiety Disorder
MM/120
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Generalized Anxiety Disorder
Psychedelics
LSD Therapy
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
major depressive disorder
Psychedelics
DMT Entities
From
Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
Tickers
FLHLF
IXHL
SILO
Tags
Methamphetamine Use Disorder
FLHLF
Markets
From
Benzinga
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
January 24, 2023
Tickers
AWKNF
Tags
Markets
News
Psilocybin program
From
Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
January 18, 2023
Tickers
IXHL
Tags
Markets
Cannabis
Market News
From
Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
January 16, 2023
Tickers
CYBN
Tags
Benzinga
Penny Stocks
Cannabis
From
Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
January 09, 2023
Tickers
CYBN
MNMD
Tags
Market News
Cannabis
Psychedelic/Assisted Therapies
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
PTSD
clinical trials
MNMD
From
Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
Tags
Psychedelics
MNMD
Small Cap
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.